Skip to main content
Clinical Trials/NCT04970758
NCT04970758CompletedNot Applicable

Differential Diagnosis Athlete's Heart From Hypertrophic Cardiomyopathy With T1 Mapping

Peking University Third Hospital1 site in 1 country60 target enrollmentStarted: January 16, 2019Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
60
Locations
1
Primary Endpoint
T1 value in ms (Unit)

Study Overview

Brief Summary

Assess the effects of strength sport to heart structure and function by T1 mapping with cardiac resonance imaging.

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 35 Years (Adult)
Sex
Male
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Same exercise

Exclusion Criteria

  • Intolerance test

Outcomes

Primary Outcomes

T1 value in ms (Unit)

Time Frame: one year

indicator of the degree of myocardial fibrosis

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Differential Diagnosis Athlete's Heart... | Clinical Trial